JP2006505577A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2006505577A5 JP2006505577A5 JP2004546105A JP2004546105A JP2006505577A5 JP 2006505577 A5 JP2006505577 A5 JP 2006505577A5 JP 2004546105 A JP2004546105 A JP 2004546105A JP 2004546105 A JP2004546105 A JP 2004546105A JP 2006505577 A5 JP2006505577 A5 JP 2006505577A5
- Authority
- JP
- Japan
- Prior art keywords
- exacerbated
- prevention
- treatment
- pharmaceutical composition
- composition according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 201000010099 disease Diseases 0.000 claims 1
- 239000008194 pharmaceutical composition Substances 0.000 claims 1
- 230000002265 prevention Effects 0.000 claims 1
- 230000004565 tumor cell growth Effects 0.000 claims 1
Claims (1)
- 腫瘍細胞の増殖によって引き起こされるかまたは悪化する疾患の治療および予防のための、請求項７に記載の医薬組成物。
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR0213270A FR2846330B1 (fr) | 2002-10-23 | 2002-10-23 | Derives de pyridoindolone substitues en -3 par groupe heterocyclique, leur preparation et leur application en therapeutique |
| PCT/FR2003/003111 WO2004037821A1 (fr) | 2002-10-23 | 2003-10-21 | Derives de pyridoindolone substitues en -3 par un groupe heterocyclique, leur preparation et leur application en therapeutique |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2006505577A JP2006505577A (ja) | 2006-02-16 |
| JP2006505577A5 true JP2006505577A5 (ja) | 2006-12-07 |
| JP4599164B2 JP4599164B2 (ja) | 2010-12-15 |
Family
ID=32088226
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2004546105A Expired - Fee Related JP4599164B2 (ja) | 2002-10-23 | 2003-10-21 | ３位が複素環式基によって置換されたピリドインドロン誘導体、それらの製造法およびそれらの治療用途 |
Country Status (13)
| Country | Link |
|---|---|
| EP (1) | EP1556380B1 (ja) |
| JP (1) | JP4599164B2 (ja) |
| AR (1) | AR041690A1 (ja) |
| AT (1) | ATE323091T1 (ja) |
| AU (1) | AU2003292285A1 (ja) |
| CY (1) | CY1105158T1 (ja) |
| DE (1) | DE60304596T2 (ja) |
| DK (1) | DK1556380T3 (ja) |
| ES (1) | ES2263033T3 (ja) |
| FR (1) | FR2846330B1 (ja) |
| PT (1) | PT1556380E (ja) |
| TW (1) | TW200418853A (ja) |
| WO (1) | WO2004037821A1 (ja) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2823975B1 (fr) | 2001-04-27 | 2003-05-30 | Sanofi Synthelabo | Nouvelle utilisation de pyridoindolone |
| FR2846329B1 (fr) | 2002-10-23 | 2004-12-03 | Sanofi Synthelabo | Derives de pyridoindolone substitues en -3 par un phenyle, leur preparation et leur application en therapeutique |
| FR2869316B1 (fr) | 2004-04-21 | 2006-06-02 | Sanofi Synthelabo | Derives de pyridoindolone substitues en -6, leur preparation et leur application en therapeutique. |
| FR2892416B1 (fr) * | 2005-10-20 | 2008-06-27 | Sanofi Aventis Sa | Derives de 6-heteroarylpyridoindolone, leur preparation et leur application en therapeutique |
| EP3919492A4 (en) * | 2019-02-01 | 2022-11-09 | Medshine Discovery Inc. | TRICYCLIC COMPOUND CONTAINING PYRIMIDINYL GROUP AS C-MET INHIBITOR |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4263304A (en) * | 1978-06-05 | 1981-04-21 | Sumitomo Chemical Company, Limited | 7 H-indolo[2,3-c]isoquinolines |
| FR2765581B1 (fr) * | 1997-07-03 | 1999-08-06 | Synthelabo | Derives de 3-aryl-1,9-dihydro-2h-pyrido[2,3-b]indol-2-one, leur preparation et leur application en therapeutique |
| FR2765582B1 (fr) * | 1997-07-03 | 1999-08-06 | Synthelabo | Derives de 3-alkyl-1,9-dihydro-2h-pyrido[2,3-b]indol-2-one leur preparation et leur application en therapeutique |
-
2002
- 2002-10-23 FR FR0213270A patent/FR2846330B1/fr not_active Expired - Fee Related
-
2003
- 2003-10-21 DK DK03767851T patent/DK1556380T3/da active
- 2003-10-21 WO PCT/FR2003/003111 patent/WO2004037821A1/fr active IP Right Grant
- 2003-10-21 AT AT03767851T patent/ATE323091T1/de active
- 2003-10-21 AU AU2003292285A patent/AU2003292285A1/en not_active Abandoned
- 2003-10-21 JP JP2004546105A patent/JP4599164B2/ja not_active Expired - Fee Related
- 2003-10-21 ES ES03767851T patent/ES2263033T3/es not_active Expired - Lifetime
- 2003-10-21 DE DE60304596T patent/DE60304596T2/de not_active Expired - Lifetime
- 2003-10-21 PT PT03767851T patent/PT1556380E/pt unknown
- 2003-10-21 EP EP03767851A patent/EP1556380B1/fr not_active Expired - Lifetime
- 2003-10-22 AR ARP030103841A patent/AR041690A1/es unknown
- 2003-10-22 TW TW092129284A patent/TW200418853A/zh unknown
-
2006
- 2006-07-12 CY CY20061100971T patent/CY1105158T1/el unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2007520565A5 (ja) | ||
| JP2003503454A5 (ja) | ||
| WO2007038459A3 (en) | Carboxyamine compounds and their use in the treatment of hdac dependent diseases | |
| WO2006032342A3 (de) | Arzneimittel enthaltend carbonylverbindungen sowie deren verwendung | |
| DE602004029580D1 (de) | Substituierte indolderivate für eine pharmazeutische zusammensetzung zur behandlung von atemwegserkrankungen | |
| EP1940373B8 (en) | 1-fluoro-1-deoxy-scyllo-inositol for the treatment of alzheimer's disease | |
| WO2007058602A3 (en) | Novel 2-amino-imidazole-4-one compounds and their use in the manufacture of a medicament to be used in the treatment of cognitive impairment, alzheimer’s disease, neurodegeneration and dementia. | |
| WO2006004449A3 (en) | A combination composition | |
| WO2007122580A3 (en) | Compositions of phenylephrine useful for treatment of respiratory illness | |
| DE602004020072D1 (de) | 1,2,3,4-tetrasubstituiertes indol zur behandlung von atemwegserkrankungen | |
| NZ593199A (en) | Milnacipran for the long-term treatment of fybromyalgia syndrome | |
| JP2008513510A5 (ja) | ||
| MY148125A (en) | Compounds | |
| JP2008513426A5 (ja) | ||
| CL2007003690A1 (es) | Compuestos derivados de 1-azonia-biciclo[2.2.2]octano; proceso de preparacion; composicion farmaceutica; y uso en el tratamiento de enfermedades pulmonares obstructivas cronicas. | |
| JP2008515980A5 (ja) | ||
| EP2586427A3 (en) | Balsalazide formulations and manufacture thereof | |
| JP2003526626A5 (ja) | ||
| WO2006108681A3 (en) | Substances and pharmaceutical compositions for the inhibition of glyoxalases and their use against bacteria | |
| IL185300A0 (en) | New pharmaceutical compositions useful in the treatment of parkinson's disease | |
| JP2008513427A5 (ja) | ||
| JP2008519810A5 (ja) | ||
| JP2005509503A5 (ja) | ||
| NO20076405L (no) | Anvendelse av 24-nor-UDCA | |
| DE602006002608D1 (de) | 4-phenyl-5-oxo-l,4,5,6,7,8-hexahydrochinolin-derivate als arzneimittel zur behandlung von unfruchtbarkeit |